Canada Life’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$134M Buy
451,980
+16,542
+4% +$4.91M 0.24% 81
2025
Q4
$119M Sell
435,438
-85,153
-16% -$23.1M 0.21% 98
2025
Q3
$142M Buy
520,591
+45,325
+10% +$12.3M 0.2% 98
2025
Q2
$131M Sell
475,266
-19,858
-4% -$5.4M 0.21% 96
2025
Q1
$132M Sell
495,124
-26,444
-5% -$6.52M 0.23% 83
2024
Q4
$121M Buy
521,568
+7,531
+1% +$1.73M 0.21% 85
2024
Q3
$114M Buy
514,037
+26,363
+5% +$5.46M 0.2% 97
2024
Q2
$95.9M Buy
487,674
+30,775
+7% +$6.36M 0.18% 108
2024
Q1
$98.5M Buy
456,899
+207,944
+84% +$43.7M 0.2% 104
2023
Q4
$52.2M Sell
248,955
-44,626
-15% -$9.52M 0.11% 179
2023
Q3
$58.8M Sell
293,581
-5,944
-2% -$1.18M 0.14% 141
2023
Q2
$55.8M Sell
299,525
-15,018
-5% -$2.78M 0.13% 152
2023
Q1
$60.3M Sell
314,543
-7,171
-2% -$1.3M 0.15% 135
2022
Q4
$54.4M Sell
321,714
-18,493
-5% -$3.21M 0.14% 150
2022
Q3
$60.2M Sell
340,207
-13,433
-4% -$2.65M 0.17% 117
2022
Q2
$72.4M Buy
353,640
+2,878
+0.8% +$610K 0.19% 110
2022
Q1
$88M Sell
350,762
-4,611
-1% -$1.08M 0.18% 109
2021
Q4
$81M Sell
355,373
-4,860
-1% -$1.07M 0.17% 116
2021
Q3
$70.1M Buy
360,233
+18,025
+5% +$3.65M 0.16% 120
2021
Q2
$72.7M Sell
342,208
-29,590
-8% -$6.25M 0.17% 125
2021
Q1
$75.5M Buy
371,798
+23,152
+7% +$4.56M 0.18% 115
2020
Q4
$63.3M Buy
348,646
+42,777
+14% +$7.27M 0.12% 185
2020
Q3
$51.1M Sell
305,869
-8,596
-3% -$1.45M 0.11% 188
2020
Q2
$50.9M Buy
314,465
+10,266
+3% +$1.84M 0.12% 185
2020
Q1
$53M Sell
304,199
-3,242
-1% -$645K 0.14% 154
2019
Q4
$61.2M Buy
307,441
+25,905
+9% +$5.31M 0.13% 166
2019
Q3
$59.5M Sell
281,536
-2,527
-0.9% -$528K 0.14% 165
2019
Q2
$55.1M Sell
284,063
-14,584
-5% -$2.69M 0.13% 173
2019
Q1
$49M Buy
298,647
+42,569
+17% +$7.53M 0.13% 173
2018
Q4
$45.9M Buy
256,078
+14,950
+6% +$2.76M 0.13% 166
2018
Q3
$41.1M Sell
241,128
-51,467
-18% -$8.66M 0.1% 211
2018
Q2
$48M Buy
292,595
+28,669
+11% +$4.68M 0.11% 188
2018
Q1
$42.6M Sell
263,926
-1,820
-0.7% -$290K 0.1% 209
2017
Q4
$38.8M Buy
265,746
+2,289
+0.9% +$326K 0.09% 232
2017
Q3
$35.7M Buy
263,457
+4,313
+2% +$545K 0.09% 232
2017
Q2
$32.4M Buy
259,144
+9,251
+4% +$1.11M 0.09% 255
2017
Q1
$29.7M Sell
249,893
-4,727
-2% -$569K 0.08% 250
2016
Q4
$29.4M Sell
254,620
-3,365
-1% -$374K 0.08% 247
2016
Q3
$26.9M Sell
257,985
-1,778
-0.7% -$186K 0.08% 261
2016
Q2
$25.2M Buy
259,763
+65,148
+33% +$6.16M 0.08% 264
2016
Q1
$18.7M Sell
194,615
-19,095
-9% -$1.74M 0.07% 281
2015
Q4
$19.4M Sell
213,710
-29,547
-12% -$2.78M 0.07% 269
2015
Q3
$22.6M Sell
243,257
-877
-0.4% -$83.4K 0.09% 235
2015
Q2
$22.7M Sell
244,134
-450
-0.2% -$42K 0.08% 273
2015
Q1
$23.1M Sell
244,584
-1,058
-0.4% -$98K 0.08% 276
2014
Q4
$21.8M Buy
245,642
+3,029
+1% +$257K 0.07% 285
2014
Q3
$19.4M Buy
242,613
+46,541
+24% +$3.51M 0.07% 307
2014
Q2
$13.9M Buy
196,072
+4,587
+2% +$323K 0.05% 366
2014
Q1
$14.1M Buy
191,485
+26,175
+16% +$1.97M 0.05% 366
2013
Q4
$13M Buy
165,310
+8,823
+6% +$691K 0.05% 363
2013
Q3
$11.5M Buy
156,487
+140,707
+892% +$10.4M 0.05% 355
2013
Q2
$1.2M Buy
+15,780
New +$1.04M 0.01% 463

Other funds holding CME

Canada Life's CME Position: Q1 2026 in Review

Canada Life increased its CME Group (CME) stake by 3.8% in Q1 2026, buying an estimated $4.91M and bringing the position to 451,980 shares worth $134M. The position accounts for 0.24% of the portfolio, ranked #81.

Canada Life first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q3 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Canada Life held 451,980 shares of CME Group worth $134M as of Q1 2026.
  • Canada Life bought 16,542 CME Group shares in Q1 2026, an estimated $4.91M.
  • CME Group made up 0.24% of Canada Life's portfolio in Q1 2026, its #81 holding.
  • Canada Life first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's CME Group position peaked at $142M in Q3 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.